Bank of America’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $726K | Buy |
|
|||||
|
2025
Q1 | $497K | Buy |
|
|||||
|
2024
Q4 | $109K | Sell |
|
|||||
|
2024
Q3 | $190K | Sell |
|
|||||
|
2024
Q2 | $259K | Buy |
|
|||||
|
2024
Q1 | $238K | Sell |
|
|||||
|
2023
Q4 | $265K | Sell |
|
|||||
|
2023
Q3 | $473K | Buy |
|
|||||
|
2023
Q2 | $602K | Sell |
|
|||||
|
2023
Q1 | $8.39M | Buy |
|
|||||
|
2022
Q4 | $5.14M | Buy |
|
|||||
|
2022
Q3 | $4M | Buy |
|
|||||
|
2022
Q2 | $2.16M | Sell |
|
|||||
|
2022
Q1 | $8.23M | Buy |
|
|||||
|
2021
Q4 | $1.64M | Buy |
|
|||||
|
2021
Q3 | $1.37M | Buy |
|
|||||
|
2021
Q2 | $2.43M | Buy |
|
|||||
|
2021
Q1 | $2.37M | Buy |
|
|||||
|
2020
Q4 | $2.58M | Sell |
|
|||||
|
2020
Q3 | $2.63M | Buy |
|
|||||
|
2020
Q2 | $2.83M | Buy |
|
|||||
|
2020
Q1 | $1.91M | Buy |
|
|||||
|
2019
Q4 | $1.61M | Buy |
|
|||||
|
2019
Q3 | $579K | Buy |
|
|||||
|
2019
Q2 | $326K | Sell |
|
|||||
|
2019
Q1 | $421K | Buy |
|
|||||
|
2018
Q4 | $557K | Sell |
|
|||||
|
2018
Q3 | $1.21M | Sell |
|
|||||
|
2018
Q2 | $1.3M | Buy |
|
|||||
|
2018
Q1 | $602K | Buy |
|
|||||
|
2017
Q4 | $408K | Sell |
|
|||||
|
2017
Q3 | $510K | Buy |
|
|||||
|
2017
Q2 | $403K | Sell |
|
|||||
|
2017
Q1 | $592K | Buy |
|
|||||
|
2016
Q4 | $431K | Buy |
|
|||||
|
2016
Q3 | $446K | Sell |
|
|||||
|
2016
Q2 | $385K | Sell |
|
|||||
|
2016
Q1 | $514K | Sell |
|
|||||
|
2015
Q4 | $967K | Sell |
|
|||||
|
2015
Q3 | $809K | Sell |
|
|||||
|
2015
Q2 | $3.41M | Sell |
|
|||||
|
2015
Q1 | $4.55M | Buy |
|
|||||
|
2014
Q4 | $1.45M | Buy |
|
|||||
|
2014
Q3 | $584K | Buy |
|
|||||
|
2014
Q2 | $741K | Sell |
|
|||||
|
2014
Q1 | $739K | Buy |
|
|||||
|
2013
Q4 | $26K | Buy |
|